Ophthalmic Business News

Harrow Health has finalized an agreement to acquire commercial rights for MAQ-100 in the United States and Canada from Wakamoto Pharmaceutical, according to a press release.

OSN New York will celebrate its 30th anniversary with an in-person meeting Oct. 15 to 17 in New York, held in conjunction with OSN New York Retina.

Santen and Sydnexis have finalized an exclusive licensing agreement for SYD-101 in Europe, Middle East and Africa for the treatment of progressive childhood myopia, according to a press release.

With summer 2021 here, more than 150 million Americans vaccinated for COVID-19, sports played in full arenas and many activities nearly back to normal, we think a column on financial lessons that can be learn from the pandemic is needed.

Molecular Partners regained the global development and commercial rights to abicipar pegol from AbbVie, according to a press release.

Ocular Therapeutix and Regeneron will no longer collaborate on the creation of a sustained-release formulation of aflibercept, according to a press release from Ocular Therapeutix.

LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Kristen Brotherson, vice president of U.S. Surgical Marketing at Alcon, discusses some of the research the company presented.

Santen is partnering with the International Agency for the Prevention of Blindness to implement United Nations General Assembly Resolution A/75/L.108, focusing on eye health and sustainable development, according to a press release.

PRECISIONeffect has acquired Pascle, according to a press release.

“I buy when other people are selling.”